UBC Publications

UBC Publications

UBC Publications

UBC Reports Jul 7, 2005

Item Metadata


JSON: ubcreports-1.0118717.json
JSON-LD: ubcreports-1.0118717-ld.json
RDF/XML (Pretty): ubcreports-1.0118717-rdf.xml
RDF/JSON: ubcreports-1.0118717-rdf.json
Turtle: ubcreports-1.0118717-turtle.txt
N-Triples: ubcreports-1.0118717-rdf-ntriples.txt
Original Record: ubcreports-1.0118717-source.json
Full Text

Full Text

VOLUME  51   I  NUMBER  7   I  JULY  7,2005
Research that Transforms Our Lives
Why UBC is the best in Canada at translating discoveries into practical, everyday advances
What do Visudyne ®, a world-leading treatment for age-related blindness and Web CT, a web
learning tool used by 10 million university students, have in common? They both incorporate
breakthrough innovation developed at the University of British Columbia. And they are each
compelling examples of UBC's unusual success at translating research discoveries into real-life
uses that benefit millions of people — a process we examine in this issue of UBC Reports.
Since 1997, UBC research funding has more than doubled to $343 million in 2004. But the
hurdles to translating that research into practical advances can be significant. They include
applying for patents, licensing technology, attracting venture capital, and organizing and staffing
new companies. It's a process that few faculty researchers could tackle on their own.
That's where UBC's University-Industry Liaison Office comes in. Thanks to its success at
coming alongside researchers, UBC ranks first among Canadian universities, and 11th in North
America, for numbers of U.S. patents granted. In total, UBC has created 117 spin-off companies.
Last year, these efforts generated $16 million in technology licensing revenue for UBC. To learn
more about the UILO's technology transfer programs, visit www.uilo.ubc.ca. □
New Device
Relief for
Those Facing
A new diagnostic device developed
by a UBC research team has got
people — including investors — talking about urinary incontinence (UI).
An interdisciplinary research trio
of technician, pediatrician and
urologist has developed a non-invasive
diagnostic tool that uses near infrared
spectroscopy (MRS) to test bladder
function. The tool will be available
for sale within two years and experts
in innovative medical technologies
predict that soon after, it will be the
new "gold standard" for diagnosing
bladder disorders.
Pediatrics critical care professor
Andrew Macnab and research
technician Roy Gagnon are the most
experienced Canadian researchers
using NIRS to measure blood flow to
the brain, particularly in infants. In
2003, they were temporarily sharing
lab space at Vancouver General
Hospital with urologist Dr. Lynn
Stothers and, over coffee, described the
difficulties they were having because
signals related to bladder function
were interfering with their NIRS study
of the spinal cord.
Stothers recognized that what was
a problem for Macnab and Gagnon
could offer a solution for the hundreds
of thousands of patients who undergo
an uncomfortable, invasive and
humiliating bladder function test.
The current technique involves
catheters inserted in the rectum and
urethra to gauge bladder pressure and
create an indirect measure of bladder
UILO manager Brad Wheeler (1) and co-inventor Roy Gagnon (r) are set to commercialize monitor
shown by Dr. Andrew Macnab.
function. It is estimated about 40 per
cent of patients with clinical symptoms
aren't properly diagnosed because they
refuse to take the test.
Based at Children's & Women's
Health Centre of British Columbia,
Macnab and Gagnon, with Stothers'
guidance, developed an external
monitor, like a large adhesive patch,
that sticks on the abdomen over the
site of the bladder. The painless exam
uses energy from light (NIRS) to
gather data about bladder health and
"A non-invasive technology means
more individuals will comply with
testing," says Stothers, who directs the
new Bladder Care Centre at UBC
Hospital, where the NIRS methods
are undergoing trials. "Also, the data
is more comprehensive — it takes the
guesswork out of diagnosis. Working
as a team and seeing the possibilities
for patients — that's been very
NIRS technology is based on
sophisticated physics. It uses photons,
or units of energy from different
wavelengths of light, diffused through
tissue. Different constituents of tissue,
such as oxygen-carrying blood cells,
absorb light differentiy. The difference
can be measured and analyzed to
monitor changes in oxygen levels and
blood supply.
Blood flow to the bladder is
important because the organ is susceptible to ischemia, or blood deficiency,
due to constriction or obstruction of a
blood vessel. Ischemia can permanentiy
impair how an organ functions.
Almost 42 million people in North
American suffer from UI and the numbers are expected to double within 20
years as the population ages. UI most
often affects middle-aged women,
long-term care residents, and those
with spinal cord injury. The condition
is a particular problem in the
developing world where childbirth
continued on page 4
UBC ranks first among Canadian universities,
4th among all Canadian organizations and
1 lth among North American universities for
U.S. patents granted between 2000 and 2004.
In Canada:
• Nortel Networks: 2,161 patents
• Siemens: 259
• National Research Council: 154
• University of British Columbia: 140
Paper One
Step Closer
Display companies testing
prototypes that use new
Anyone who's ever had trouble
reading their cell phone or PDA display will appreciate a new technology
being developed at UBC's Structured
Surface Physics Laboratory (SSP) that
promises to deliver electronic displays
as clear as ink on paper.
Based on an invention of UBC
Vice President Academic and Provost
Lome Whitehead — who is also chair
of SSP — the "electronic paper" has
received 15 U.S. and international
patents and provided the foundation
of a spin-off company — aptiy
named CLEAR Display Inc.
Conventional liquid crystal
displays (LCDs), which use
fluorescent backlighting and layers of
liquid crystals against a glass-like surface to create images, show up poorly
in strong, external light sources.
"This is why in the sun, it's really
hard to read your PDA or cell
phone," says Michele Mossman, a
research associate in the Department
of Physics and Astronomy, and the
primary UBC researcher developing
the technology.
Several years ago, Mossman and
Whitehead invented an approach that
takes advantage of a well-known
physics phenomenon called Total
Internal Reflection (TIR) that enables
the display to create crisp, high-
contrast and high-resolution images
comparable to ink on paper.
By adding microscopic optical
hemispheres on the back of a thin,
plastic film, they have created a
continued on page 2 I      UBC      REPORTS       |      JULY     /,      2005
Retiring Within 5 Years?
Don Proteau
B.Comm, CFP
Senior Financial
Planning Advisor
Assante Financial
Management Ltd.
Frank Danielson
B.Ed., CFP
Senior Financial
Planning Advisor
Assante Financial
Management Ltd.
♦ Complimentary consultations available for
UBC Faculty and Staff
♦ Retirement and Estate planning
♦ UBC pension expertise
♦ References available
"/ am completely satisfied with the service I am receiving from Don. "
M. Dale Kinkade,
Professor Emeritus of Linguistics, UBC
"Frank and Don made me feel very comfortable with their advice and
long range planning. Their knowledge of the faculty pension plan is
also a plus for UBC professors."
Dr. J. H. McNeill,
Professor, Pharmaceutical Sciences, UBC
Call or e-mail today for a complimentary retirement analysis
p= Assante
The Assante symbol is a registered trademark of Assante Corporation, used under license.
Deprez & Associates
Notaries   Public
• Real Estate transfers
• Re-financing
• Wills & Powers of Attorney
• Affidavits & Statutory Declarations
2515 Alma Street (between W. 10th and W. Broadway)
www. notarydeprez. com
Berkowitz & Associates
Consulting Inc.
Statistical Consulting
research design • data analysis • sampling • forecasting
Jonathan Berkowitz, Ph.D
4160 Staulo Crescent, Vancouver, B.C. V6N 3S2
Office: (604) 263-1508 Fax: (604) 263-1708
Victoria Bell
Your University
Area Specialist
Top Volume Producer Dunbar Office
Member MLS Medallion Club
1999/2000/2001/2002 /2003/2004
Cell 604-209-1382
My real estate goal is to build integrity based relationships
backed with an extremely high commitment to professionalism
and accountability. I offer 26 years of success and experience.
Please call me for any university real estate market information,
current evaluation of your property or any real estate assistance
that you may require.
EMAIL: public.affairs@ubc.ca
Walk-In Clinic
604-222-CARE (2273)
Universiry Village Medical/Dental Clinic
Walk-ins and Appointments « Extended Hours
Conveniently located in the UBC Village above Staples
#228-2155 Allison Road, Vancouver, BC V6T 1T5
Highlights of UBC Media Coverage in June 2005. CO MPiled BY Al lin choo
Dairy products help you lose weight.
Fact or myth?
Drink Milk and Lose Weight?
The Physicians Committee for
Responsible Medicine is challenging
the scientific validity of the claim that
dairy products help one lose weight
— as seen on TV and print ad
promotions from the milk industry
and sellers of yogurt and cheese.
Susan Barr, a UBC professor of
nutrition, told The New York Times
that it's still unclear whether milk or
other dairy products do in fact help
individuals lose weight.
"More studies need to be done
to try and confirm this."
Bacteria Photosynthesize
Without Sunlight
UBC's Prof. J. Thomas
Beatty and
his colleagues have found a
photosynthetic bacterium
that doesn't live off the light
of the sun. It instead uses the
dim light given off by
hydrothermal vents some
2,400 metres below the
ocean's surface.
The research team first
encountered the bacterium,
GSB1, in samples collected
from a vent field located off
the coast of Mexico, reports
Scientific American.
DNA analysis identified
the organism as a member of the
green sulphur bacteria family that
relies solely on photosynthesis to survive. Scientists say the results are startling as it allows them to consider
other places where one might find
photosynthesis on Earth, as well as
other planets.
Ballooning to the Stars
The adventure portion of the mission
known as the Balloon-borne Large
Aperture Submillimetre Telescope
(BLAST) is now over, and if the
science part of the experiment goes as
well as the first, scientists expect to
provide answers to a major cosmological mystery, reports The Toronto Star.
"We're basically looking at dirt. It
seems quite unglamorous. It's like
snow and ice and carbonaceous stuff
all mixed together into very fine
grains, smaller than anything you'd
get in a snowstorm," says team
member Mark Halpern, a UBC
astronomy professor.
BLAST, a Canada-US. telescope,
cruised all the way over from Sweden
in just four days this past month,
carried 40 kilometres high by a
33-storey balloon.
Pedophile-Tracker was
Brad Willman, a self-described
computer geek, spent four years
tracking down pedophiles by hacking
into peoples computers from his
parents' home in Langley.
Willman was ultimately reponsible
for the arrests of about 40 pedophiles
across Canada and the United States,
but some think Wilman himself
should be punished.
"The way the information was
collected is not appropriate," Prof.
Hasan Cavusoglu from the Sauder
School of Business told Maclean's
Magazine. "It may challenge the
foundation of many institutions we
all rely on if everybody starts to do
what they deem to be right. We
should all abide by the laws." □
Electronic Paper
One Step Closer
continued from page 1
surface that is receptive to coloured
pigment particles, which absorb
rather than reflect light.
"We can use an electric field to
cause the pigments to gather in
desired regions to form images. In a
way, it is a bit like the children's toy
called the Etch-a-Sketch," says
Mossman.   "By selectively removing
particles from a surface, an image
can be created. But in our case, this
happens in just milliseconds and
yields strong contrast.
"Since TIR is essentially 100 per
cent efficient and the hemispheres
reflect ambient light, very little power
is required and the quality of the display is good under a wide range of
lighting conditions."
"We're now working with a few
display companies in prototype
development and to explore the
potential of incorporating the
technology into existing displays,"
says Mossman, who adds that the
paper-like quality of the display will
Michele Mossman is developing an electronic display that is as clear as ink on paper.
enable tools such as electronic books
to become much more user-friendly.
A Massachusetts Institute of
Technology spin-off company called
E-ink is working on one of the
competing technologies on the
market. While commercial products
are already being sold based on the
MIT technology, it only achieves
about half the maximum reflectance
of CLEAR displays, which under
common lighting conditions exceeds
that of white paper.
" One of the most exciting aspects
of this technology is its positive
environmental potential," says
Whitehead.   " In today's world of
electronic information it is a shame
that so much paper is wasted in
order to display information in an
easy-to-read, portable form. We
hope this work will bring 'electronic
paper' one step closer to reality." □
Director, Public Affairs
Scott Macrae scott.macrae@ubc.ca
Randy Schmidt randy.schmidt@ubc.ca
Design Director
Chris Dahl chris.dahl@ubc.ca
Sharmini Thiagarajah sharmini©exchange.ubc.ca
Principal Photography
Martin Dee martin.dee@ubc.ca
Lorraine Chan lorraine.chan@ubc.ca
Ai Lin Choo ailin.choo@ubc.ca
Brian Lin brian.lin@ubc.ca
Hilary Thomson hilary.thomson@ubc.ca
Sarah Walker public.affairs@ubc.ca
UBC Reports is published monthly by the UBC Public Affairs Office
310 — 6251 Cecil Green Park Road
Vancouver BC Canada V6T IZI
UBC Reports welcomes submissions.
For upcoming UBC Reports submission guidelines, please see
www.publicaffairs.ubc.ca/ubcreports/about. Opinions and
advertising published in UBC Reports do not necessarily reflect
official university policy. Material may be reprinted in whole
or in part with appropriate credit to UBC Reports.
Letters (300 words or less) must be signed and include
an address and phone number for verification. Submit letters to:
The Editor, UBC Reports
UBC Public Affairs Office
(address above); by fax to 604.822.2684; or by e-mail to
randyschmidt@ubc.ca or call UBCNEWS (604.822.6397) UBC      REPORTS       |      JULY     /,     2005      |      3
UBC's Serial Entrepreneurs
Some faculty have been unusually productive in earning patents and starting
spin-off companies, byai lin choo
Robert Hancock will readily admit it
was romance that guided him to
become a scientist. He remembers he
was in his last year of high school
when he became struck by what he
saw in a magazine.
The object of his affection: penicillin.
"I had decided I was going to be a
scientist before, because I felt a scientist
is someone who produces something
useful," said the UBC professor of
microbiology and immunology.
"But after I read the article on the
discovery of penicillin, which seemed to
me the most romantic adventure I had
ever read, I was certain. And I never
thought of anything else."
What certainly never crossed his
mind was that his love affair would
one day reach beyond antibiotics to
encompass business.
He certainly never planned on
becoming one of the most successful
entrepreneurs at UBC.
Hancock, who has become
renowned for his work in trying to
boost the body's natural immunity to
combat infection, says that when he
was growing up, a scientist would
never have considered working with
Still, it was about 15 years ago that
Hancock filed his first patent, and his
technologies have since been licensed to
four companies. Currently, the latest
company he co-founded, Inimex
Pharmaceuticals, a UBC spin-off company, is working on treating infections
without solely relying on chemicals, but
by trying to boost natural immunity.
"Scientists back then never really
formed companies. The academic
climate was hostile towards it,"
explained Hancock. "You would quite
simply be considered a 'sell-out.'"
He says initially he was quite
content to publish articles and
contribute by advancing knowledge
without thoughts of seeing his research
through in an overtly practical fashion.
"It was only when I got involved
with Canada's Network of Centres of
Excellence in 1989, which was
designed to try move technology from
the university sector into industry, that
I started thinking about it," he said.
"I suddenly realized that if you're
going to see your work turn into something useful, you have to take a bit
more responsibility for it."
Over the past two decades, UBC has
been witness to a new trend that has
not only disrupted longtime academic
principles, but has also taken the field
of academia to a whole new level.
Like Hancock, other researchers
have also been inspired to market their
technologies to secure higher amounts
of funding for their work, and turn
their ideas into practical spin-offs.
Steven Pelech, UBC professor of neurology and founder and president of
Kinexus, is another successful serial
entrepreneur who tells a similar career-
changing tale.
Unlike Hancock, working with
industry began quite early for him,
when he realized he was more
interested in systems biology and
discovery-based research than the
more traditional scientific method of
testing hypotheses based on limited
Pelech says his kind of research was
simply "not in vogue" at the time.
He was trying to discover new types
of protein kinases, enzymes that have
been implicated in hundreds of
He explains this type of discovery is
Serial entrepreneur Robert Hancock is a professor in Microbiology and
an integral step in drug development as
investigating these proteins can lead
researchers to find drug compounds
that may control their activity.
"So, soon after I began research at
UBC, I was approached by a company
who offered me a deal. We were isolating antibodies and they said that if I
gave them some of our antibodies, they
would give us a royalty," he said.
Pelech felt that selling antibodies
would be a good way to increase the
amount of funding he received for his
Now, two companies later, the first
of which, Kinetek Pharmaceuticals Inc.,
was recently bought by Vancouver-
based QLT PhotoTherapeutics Inc.,
Pelech has filtered his interests into a
unique type of proteomics service that
has aided more than 600 drug companies and academics in measuring how
kinases behave in the context of cells.
His present company, Kinexus, will
also be launching an online database
this summer that will enable subscribers to compare these proteins
across hundreds of different model
"By continuing to steer our research
toward practical outcomes, we can
maximize the prospect that our efforts
can benefit the scientific community
and the public the most," Pelech
"The university has been great and
supportive of us, but things still haven't
changed completely. There's still hesitation for many who can't accept us
working with industry."
The two professors say there exists
no blueprint, training program or set
of strategies that they can pinpoint as
integral to a research entrepreneur's
"Ijust simply love my dayjob,"
said Hancock. "I had no plan when I
got into this. Who knows what I'll be
when I eventually grow up." □
Other UBC Serial
Entrepreneurs Include:
• Prof. Emeritus A. Chaklader,
Materials Engineering
• Prof. Dale Cherchas,
Mechanical Engineering
• Prof. Pieter Cullis,
• Prof. Nicolas Jaeger, Electrical
and Computer Engineering
• Prof. Karim Qayumi, Surgery
• Prof, and Chair Hennie van
Vuuren, Food Biotechnology
• Prof. Lome Whitehead,
Physics and Astronomy
• Prof. Ian Yellowley,
Mechanical Engineering
To date, UBC has created 117 spin-off companies. Royalties and
technology licensing revenues flowing back to UBC in 2005 were
nearly $16 million. □
Guest Accommodation
near UBC
A Harbourview Retreat
Bed & Breakfast
Ask about our UBC Discount!
4675 W. 4th (at Blanca)
Vancouver, B.C.
West Coast Suites
at The University of British Columbia
Here is the perfect alternative for a stay in Vancouver. Surrounded by the
spectacular beauty ofthe UBC campus, our fully-equipped, quality suites
offer convenience and comfort for visiting lecturers, professors, family,
friends or anyone who wants to stay on Vancouver's west side. Close to
restaurants and recreation both on and off campus, and only 20 minutes
from downtown Vancouver, the West Coast Suites is a wonderful retreat from
which to visit friends or make your stay on business a pleasure.
Reservations Tel 604 822 1000  Fax 604 822 1001
5961 Student Union Boulevard Vancouver BC V6T 2C9
f Conferences and
at The University of British Columbia
Open Year-Round
Convenient On-Campus Location
An Affordable,
Fully-Equipped Suite
Right on Campus
The Iona Building at Vancouver School of Theology on the UEC c
Stay, work and play
In our forest by the sea. We offer the best range of affordable
accommodation, meeting space and conference services in the
Lower Mainland. Come find out why.
5961 Student Union Boulevard
Vancouver BC V6T 2C9
Tel 604 822 1000
Fax 604 822 iooi
Group Sales and
Conference Services
Tel 604 822 1060
Fax 604 822 1069
yp Conferences and
^P Accommodation
at The University of British Columbia
Copies Plus
1950 West Broadway
Vancouver, BC
Now in our 18th year! QUALITY • SERVICE • VALUE
Quality Digital Printing and Copying Service
• Reports • Newsletters • Booklets • Training Manuals • Overhead Transparencies
• Powerpoint Handouts • Flyers • Resumes • Sell Sheets • Presentation Folders
• Email your files to us • you can also ftp your large files to us
• Competitive prices • Open 7 Days a week
Mon to Fri 8am-9pm • Sat to Sun 10am-6pm
Crest Realty (Westside)
RE/MAX Real Estate
Specialist - UBC/Westside
Elaine Kadla 604.323.6795
ekadla@remax.net www.elainekadla.com
I am a UBC Faculty wife and I live and work
in the area. My insider's knowledge of the
University and the area will help to get you
the best return on your investment.
Whether buying or selling real estate, I can help
• REtocATiON customer service beyond finding
the perfect home. I understand
the specific needs of university
• selling       re;max outspends the competition on
advertising more than the top
6 competitors combined
• buying       re;max Agents average 3X more
successful negotiating than the
ndustry average
For a complimentary copy of Common Sellers Mistakes
or Home Buying Step by Step please call 604.323.6795 4     I
REPORTS      |      JULY     /,      2005
UILO Director Pilots Great Ideas to Market
But it's about much more than money says the guiding force behind Canada's most successful technology transfer office, by Lorraine chan
Gliding would strike any sane soul as
a pastime rife with risk. But somehow
it makes sense that flying an engine-less
aircraft features high on Angus
Livingstone's favourite to-do list.
"To understand it, you get in a sail
plane and you get hooked behind a
power aircraft and they tow you to
2,000 feet and they release you,"
explains Livingstone, managing director
of the UBC University-Industry Liaison
Office (UILO), who describes himself
as "a good reasoned risk taker."
"You're looking to find areas of lift,
where the air is rising. You want to get
yourself to an altitude where you can
set out and move abroad, and eventually land, typically at an airport, but
sometimes in a farmer's field," says
Livingstone, who with a laugh recounts
how he once landed  "falling out of the
sky like a lawn dart" in the middle of
some unimpressed golfers in Salmo,
Soft-spoken and articulate,
Livingstone draws parallels between
gliding and his mandate to translate
great ideas into marketable ventures.
"The ability to be out there, to take
a calculated risk, to read the air currents and yet still find your way forward so you get from one point to
another is probably very similar to the
kinds of things I'm doing now."
Livingstone joined the UILO in
1988, only four years after he had
earned a UBC computer science degree.
Since then, he has helped UBC established the premier technology transfer
office in Canada, gaining a worldwide
reputation for innovative research incubation and company spinoff.
"Angus has an almost unique and
very valuable capability to understand
and build bridges between the
researchers in academia and investors
in the financial world," observes Basil
Peters, co-founder of BC Advantage
Funds and Fund Manager of the BC
Tech Fund, an early-stage investor in
UBC spin-off company Sunnybrook
Livingstone says he joined UILO
because of his "vicarious pleasure in the
research achievements of others." This
in no small part has been one of his
strengths coupled with a principled
approach to business.
"I've always thought of Angus as the
heart and soul of tech transfer in B.C.,"
says Dr. Donald Rix, chair and one of
the founders of MDS Metro
Laboratory Services, the largest independent community laboratory in B.C.
"He asks very good questions, difficult questions about conflict of interest.
It's a small community here and he's
always very good at reminding us to
keep on the right path," says Rix, who
New Device Promises Relief for Those Facing
Bladder Disorders continued from Pagei
complications leave many women
with damaged bladders.
"I couldn't really believe the potential impact of our modification of
NIRS and I wasn't sure about switching my research career focus from
brain to bladder," says Macnab. "I
wasn't completely sold on the whole
idea of commercialization — I needed
some convincing."
That was Brad Wheeler's job. As a
University-Industry Liaison Office
(UILO) technology transfer manager,
he led the commercialization effort
and worked with Stothers, Macnab
and Gagnon to assess the market for
the technology and explain how they
would be supported through the
patenting and commercialization
"Licensing the use of NIRS in urology is a great example of commercialization being the most effective way to
get new technology to physicians and
their patients," says Wheeler.
Last month MDX Medical, a
Vancouver-based company that commercializes medical device technologies, announced the finalization of the
licensing agreement with UBC and
acquisition of rights to the technology,
which they will develop and sell
"Because we've worked with NIRS
for years, we've been able to adapt it
quickly and inexpensively," says
Gagnon, who has worked with
Macnab for 15 years. "It's exciting for
me to develop a device that directly
benefits patients. Eureka! We finally
did it."
MDX has termed the technology
"disruptive," which means that the
current diagnostic technology for UI
will be made obsolete when NIRS hits
the market. Further validation came
from the American Urological
Association, which last year gave their
top research award to Macnab,
Stothers and Gagnon.
Macnab says one of the most satisfying parts of the commercialization
journey is knowing for sure that his
research will translate rapidly into a
benefit for patients.
He, Gagnon and Stothers will further refine the technique and software.
MDX is building a clinical prototype
of the equipment and sponsoring the
clinical trials required for Health
Canada approval before the technology is made available for regular clinical use.
Research at Vancouver General
Hospital is part of Vancouver Coastal
Health Research Institute (VCHRI).
A joint venture between UBC and
Vancouver Coastal Health, VCHRI
promotes development of new
researchers and research activity.
Children's & Women's Health
Centre of British Columbia is an
agency of the Provincial Health
Services Authority, and includes BC
Children's Hospital and Sunny Hill
Health Centre for Children, and
BC Women's Hospital & Health
Centre. □
was an investor in UBC spin-off company QLT and the recent donor of $4
million that will help support UBC
medical students.
"Everybody knows he's fair, but
also they know he's not a push-over.
He defends the university side, he's a
good negotiator," says Dr. Rix, a B.C.
entrepreneur and medical professional
who over the past 15 years has served
on several biotech company advisory
boards with Livingstone.
Livingstone agrees that he has a
knack for building consensus among
venture capitalists, government and
academia. He lives by the tenet, "We'll
all win, if we create a bigger pie for
One such bigger pie is Genome BC,
a large-scale research organization
that has garnered $173 million in federal, provincial and other funding for
projects and core facilities. Genome
BC founding president Roger Foxall
says that Livingstone brought welcomed expertise on setting up a
framework to manage intellectual
property rights.
"With input from Angus, Genome
BC put forward the clear management
terms under which the Genome
Canada funds would flow through us
to the institutions," says Foxall, new
Genome BC's executive vice president
of corporate development.
"There was concern across the
country regarding intellectual property
rights and we were the first to tackle
the problem, and to an extent, acted
as a model for other centers," he says,
explaining that since its creation in
2000, Genome Canada has distributed $386 million among five regional
"I've got a great mind in terms of
puzzling," reflects Livingstone. "lean
take a relatively complex mix of emotions, facts and situations and see my
way clear to a resolution, and then put
it out in a non-confrontational way.
That way people can feel like their
needs are honoured, instead of being
Fractal Capital Corp President Haig
Farris, a well-known venture capitalist
and investor, praises Livingstone for
his canny pragmatism.
"Angus has a good sense that there
are way more ideas at UBC than UBC
has the money or time to commercialize. History shows that rich graduates
give more money back to the university so you might as well license technology out to graduates who are starting new businesses."
But Livingstone says he always
looks at the greater value when backing a new venture.
" If there were a money-making
scheme just to see how much cash we
can crank out of this and I don't see
an innate advancement for society, or
quality of life, or any kind of benefits
that we can think of, I'm just not
interested in it."
Livingstone refers to a Utopian
vision of Earth shown in the Star Trek
television series — "not in the original
series, but in The Next Generation.
"They've eradicated hunger, and
they've eradicated disease. We're no
longer warring with each other, and
we're not producing just to consume,
but we're producing to meet our needs
in some sort of harmony with the
"Those are pretty noble goals —
probably not going to get reached in
my lifetime," says Livingstone, "but if
I can make a contribution towards
that then that's really the ultimate in
personal fulfillment." □
Economic Impact
Five of the largest public traded technology companies in B.C. are UBC
spin-offs. Another two are based on UBC-developed technology. The
total market capitalization of these companies is $5.8 billion.
A 2003 survey showed that UBC spin-off companies employed 2,000
people, and had a combined revenue of more than $300 million. □ UBC      REPORTS      |      JULY     /,      2005      |      5
Endangered Sri Lankan
Plants Live on in New
—I l_l L_I t I l__» JJ..-11 a u.
Ifyou think naming your pet is
stressful, try naming an entire
species of flowers.
That's the task faced by UBC
assistant professor Andrew
Riseman at the Botanical Garden
in the Faculty of Agricultural
Sciences. But
you won't
hear him complain, because
it took him a
lot more work
to create the
flower he now
has the privilege to name
and is about
to commercialize.
"For the common name, I'm
thinking of using something that
has to do with the flower's vibrant
colour, maybe a play on words
from the blues genre," says
Riseman. "However, I'd also like a
name that honours Sri Lanka,
where the five species of exacum
used to create the new flower
Riseman began studying
Exacum affine — or Persian violet, a common ornamental plant
available in most grocery stores —
as an undergraduate student at
Pennsylvania State University.
Since then, he has crossed five
endangered wild species from the
gentian family and cultivated 13
generations of interspecific hybrids
to arrive at a commercially viable
plant — something Japanese and
Dutch researchers have not been
able to accomplish in 30 years.
" It's still very much a work in
progress," says Riseman, who
came to UBC five years ago with
the germplasm, or genetic information, he had worked on
throughout his Master's and PhD
studies. "But we feel the crop is
now strong enough to introduce to
growers and the public."
Each of the six genotypes of the
exacum Riseman developed yields
large blue flowers with bright yellow anthers, and is suitable for
either the greenhouse, cut flower
or house plant markets.
From this point on, Riseman
says, it's up to
growers to
what precise
maximize the
plant's growth
"We're probably two to
three years
away from
seeing them on the market."
With plant patents pending on
several advanced selections,
Riseman, who is involved in
commercialization for the first
time, acknowledges the expertise
provided by the University-
Industry Liaison Office.
"They have been instrumental
in identifying and protecting the
intellectual property, in helping
create a business model for
introduction, and in developing
and managing Material Transfer
Agreements, which are required
before sending the exacum to
growers for commercial trials."
As exciting as it is to create a
whole new plant classification for
the public's enjoyment, Riseman
says a better understanding of its
underlying biology will be the
blue blossoms' lasting legacy to
" Exacum is reported to be one
of the fastest evolving group of
plants," says Riseman.
"Understanding the evolution of
its genome, and its interactions
and synergies with other plants
may prove to be very interesting
to many areas of biology beyond
horticulture." □
Prof. Andrew Riseman has developed six genotypes of a new breed
of exacum for commercialization.
An Alternative View: Prof Makes Innovative Animation Codes Open Source
Prof. Robert Bridson's animation
software modules will simulate
toothpaste movement.
Ifyou were convinced that British
child actor Daniel Radcliffe really
could fly when he straddled the
magic broom in Harry Potter and
the Chamber of Secrets, you have
Robert Bridson to thank.
Bridson, 28, from the Imager Lab
for Graphics, Visualization and
Human Computer Interaction at
UBC's Dept. of Computer Science
(see sidebar), was instrumental in
developing software modules that
made Potter's cape appear to fly naturally as he whipped through the air in
a fierce game of Quidditch.
The modules allow animators to
quickly and realistically simulate the
movement of cloth and were developed by Bridson while working on
his PhD at Stanford University. The
effects were so realistic that the codes
were immediately adopted by
animation powerhouse Industrial
Light + Magic — founded by George
Lucas — to make the last two Harry
Potter movies and Star Wars: Episode
II - Attack ofthe Clones.
Now Bridson is putting that
experience to good use in perfecting
modules that simulate water
and other complicated fluid
Based on the
laws of
codes are
poised to make
waves in an
industry where the
yardstick for excellence is
looking "normal."
"It will save animators a tremendous amount of time," says Bridson.
That's because movement of
everything from surf to toothpaste
could be modeled quickly and
realistically with the click of a button.
"Despite the advances in graphics
technology, modeling simple
movements of cloth and water
remains one of the biggest challenges
for animation software programmers, " says Bridson, who once
aspired to be an animator himself.
"And if they're not realistic, the
audience would instantiy sense that
something looks odd because
we're so used to seeing the correct
While there is no doubt about
the potential commercial value of
Bridson's codes — which he has
slaved over in the two years since he
arrived at UBC — he'll make them
readily available over the Internet
when he completes the project at the
end of the summer.
"Visual effects studios are not paid
according to how well the movies do
in the box office," explains Bridson
as to why he won't go the conven
tional commercialization route. "The
truth is most of them are struggling
just to stay in the black, so there isn't
a huge amount of money to be made
"By making the codes open source,
animation software programmers can
immediately make use of the modules
to develop better tools, and other
researchers in the field will be able to
reference my work and create even
better modules," adds Bridson.
" I think it's a healthier approach for
the industry as a whole."
For more information, visit
www.cs.ubc.ca/~rbridson. □
Established in 1989, the Imager Laboratory for Graphics, Visualization
and Human Computer Interaction at the Dept. of Computer Science is
one of North America's top research groups in the area of computer
With an impressive list of clients and supporters in the entertainment,
engineering design and e-commerce industries — including Pixar,
DreamWorks, IBM and Sun Microsystems — researchers at the Imager
Lab conduct groundbreaking research in both the physical and psychological aspects of our increasingly intimate relationship with technology.
The Lab's close industry ties means timely application of the research
to animation and visual effects of blockbuster movies, the design and
construction of skyscrapers and airplanes, and even medical education.
For more information, visit http://www.cs.ubc.ca/labs/imager/ □ 6     I
REPORTS      |      JULY     /,      2005
Research CEO aims to Shorten Drug Development Process
Natalie Dakers is CEO of the Centre for Drug Research & Development that will mature
early stage technologies.
To find a unique perspective on
how UBC commercializes research,
just talk to Natalie Dakers.
Having been a research scientist,
technology transfer manager,
spin-off company co-founder and
CEO, chair of BC Biotech, vice-
president of the Association of
University Technology Managers
and now CEO of the Centre for
Drug Research and Development,
Dakers feels she's grown up with
the biotechnology industry.
After graduating from University
of Guelph with an honours degree
in marine biology, Dakers worked
as a research biologist for a B.C.
salmon aquaculture company. In
1989, she joined UBC's University-
Industry Liaison Office (UILO)
where, as senior manager for life
sciences technology transfer, she
learned about
venture financing,
licensing agreements and the
complex world of
"I was lucky
enough to work
with creative
people in an office
that was leading
the way in tech
transfer in
Canada," says
She acknowledges that there
are strong and
polarized feelings
on commercialization — some
believe it doesn't
fit with the
research and
education mandate
of a university.
" If you do it
right, you can
enhance a
reputation," she
says. "A spin-off is
the vehicle to
enable discovery."
After eight years
and helping to create more than a dozen spin-offs,
Dakers decided she "had done
enough facilitating and wanted to
get in the game."
She had worked with UBC
neurobiologist Terry Snutch on
some research contracts and was
impressed with his "stellar
science." He has developed
compounds to block calcium channels in the brain that transmit pain
signals. The drugs are aimed at
patients with chronic pain and
other severe neurological disorders,
such as epilepsy.
The pair — with no formal business training between them —
launched Neuromed Technologies
Inc. in 1998 to commercialize
Snutch's ideas in developing pain-
killing drugs.
"Early on I could have simply
licensed out the technology and
walked away," says Snutch. " It's
been a very long road but the
experience has been worth all the
effort — there hasn't been a dull
moment. And although there's still
a long way to go, we based
Neuromed on solid scientific
rationale and never wavered from
the original concept of drug development as the best way to create
and maintain value.
"I jumped in and never looked
back," says Dakers. "We were passionate about what we were doing.
We never lost faith."
But their faith was tested. In
January 2002, the first compound
failed at a critical point in the
financing process. It was one of the
sickening plummets in what
Dakers calls the roller-coaster ride
of running a spin-off. She spent a
year getting investors excited once
again about the venture and the
second compound they were set to
By January 2003, she had raised
a total of $70 million for
Neuromed, which propelled it
toward what she describes as her
proudest moment — when the first
clinical trial participants received
doses of calcium channel blockers.
But with that success came a
very difficult decision. In October
2003, Neuromed had secured the
third round of financing. The
agreement with lead investor,
MPM Capital, meant the company
would have a new CEO operating
from the U.S. Dakers had to let go
of Neuromed, although the
research base remains in Vancouver
and Snutch continues as vice-president and chief scientific officer.
Now CEO of the Centre for
Drug Research & Development
(CDRD), Dakers has a new
vantage point on commercializing
The UBC-based centre is
responding to new demands in the
investment environment. Investors
now want ideas at a later stage of
development. Activities at the
centre will mature early stage technologies, adding value and
reducing risk.
"The centre represents an
important stage in the evolution
of B.C.'s biotech industry," Dakers
says. "We want to bridge the commercialization gap between new
technologies and investment. The
centre will enable us to attract and
keep investors for our spin-offs."
Drug development is an exercise
in patience, she says, noting that it
takes 10-12 years to get a
discovery to market.
"We need more than talk and
four-year funding cycles to
maintain an environment of
innovation in Canada. We need
long-term commitment and action
to realize our potential. The centre
is a proactive part of that," says
Dakers. "We've had spectacular
ventures like [UBC's most
successful spin-off company] QLT
and we can have them again. I've
always believed it's possible." □
www. chance] UBC      REPORTS       |      JULY     /,      2005      |      7
New Ovarian
Cancer Test
on Horizon
Rejection of first discovery,
spurs development of better
A medical researcher's desire to
help others can often be a painstaking
adventure in patience, says Nelly
Auersperg, a UBC professor in
Obstetrics and Gynaecology.
She learned this the hard way nine
years ago when she realized her
newly discovered technology — one
that could tell if a woman had an
increased chance of getting ovarian
cancer and possibly help prevent it —
would never make it as common
In 1998, Auersperg found that
tissue cultures taken from some
women with family histories of
ovarian cancer were significantly
different from others. She was certain
that if developed into a test, there
could be a way to predict if these
women would fall prey to the disease
at a future date.
"I was so thrilled. There's currently
no way to detect early stages of
ovarian cancer because there are no
early symptoms of it. That's why it's
known as deadly, because it's almost
always diagnosed at too late a stage,"
she explained.
Auersperg, who has been researching cervix and ovarian cancer all of
her career, immediately contacted the
University-Industry Liaison Office
(UILO) and patented the technology.
The office was similarly hopeful,
but soon found that getting
companies to share in their excitement would prove slightly more
Because the test would require
scraping the ovaries to get a tissue
sample, there was an overall reluctance on the part of companies to get
involved, says Barbara Campbell, a
UILO technology transfer manager.
"When we tried to contact them
to market the idea and develop it, we
kept getting asked the same
questions. Could the average hospital
technician perform the procedure?
Could it be put into a test kit? Could
it be done as a non-invasive
procedure? The answer was 'no' to
all of them," said Campbell.
The office realized that unless the
idea could be turned into a quick and
easy kit, there would be little interest
in developing the technology.
"Commercial off-shoots are great
because researchers get to see their
work materialize into public use,"
said Campbell. "But this technology
was a simple reminder that even
though UBC researchers come up
with the most innovative of ideas,
they do not always lend themselves
to the marketplace."
Campbell explained that even
when companies do come on board,
an idea can take anywhere from two
to 10 years to materialize. At UBC,
the technology must first go through
a thorough assessment by the UILO,
and the office will only take it to the
development stage if it is proven to be
both marketable and patentable.
Researchers are often left frustrated
because soliciting company interest
and investment can often be the make
or break point of a new discovery,
said Auersperg. While her results
have been tremendously successful
from a journal-publishing point of
view, she says scientists have to rely
on industry to take their research to
the next level.
"We simply do not have the
resources to do any further
development on our own. A medical
technology company, for example,
will have maybe 20 to 30 scientists
working on one thing with
considerable sums of money backing
2?^T^**iJ  *
Histologic sections through normal ovarian surface epithelium (OSE)
(left) and a region of OSE with early premalignant changes (right).
The protein is currently being investigated as a cancer diagnostic marker.
their efforts," she explained. "Yes, I
was disappointed that my research
couldn't be marketed, but no, I didn't
give up."
And Auersperg's efforts may still
pay off. With the help of Michelle
Woo, a PhD student, she says she
recently made a new discovery that
may potentially detect early-stage
ovarian cancer by means of a blood
Five years ago, Auersperg was
approached by Woo at a conference
in Hong Kong. Intrigued by the
professor's work, Woo asked if she
could come to Vancouver and pursue
ovarian cancer research under her
Since then, Woo has identified a
protein expressed in low grade
ovarian cancer that is different from
non-cancerous tissue and late, high
grade cancers. She explained that
because this protein is secreted by the
cancer cells, it may show up in blood
serum and it might be possible to
detect through blood testing.
"The idea is that if we can develop
this into a blood test that would be
performed on high risk women, we
might be able to save more lives,"
said Woo. "We're also beginning to
find that this procedure could also be
useful in detecting cancer of the
The two have since approached
UILO, and their technology is now
being shown to investors.
For her part, Auersperg hopes
companies may have fewer reservations about the new procedure.
Despite two previous failed patent
applications, she has also previously
obtained two commercial agreements
with the help of UILO, both in the
field of ovarian cancer detection, and
feels all her efforts have been worthwhile.
"I've been using public funds to
support my research for decades and
I'd like to feel useful. This isn't all
just for my personal entertainment.
I'd like to give back in some way and
this is the best way I feel I know
how," she said.
"If nothing else, even if it doesn't
work, it still helps us understand
ovarian cancer and may help other
researchers figure out how we can go
about diagnosing and treating it." □
2005 UBC Tech Transfer Overview
• $364 million total estimated UBC research funding
• 143 technology disclosures
• 276 patents filed; 136 U.S. patents filed
• 55 patents issued; 22 U.S. patents issued
• 2 new spin-off companies (total of 117)
Professor Emeritus Receives
Order of B.C.
Felix A. Durity, a recendy retired
member of UBC's clinical medical
faculty, received the Order of British
Columbia June 29.
The order recognizes the
accomplishments of outstanding
citizens who have contributed to
strengthening the province in a
variety of exceptional ways.
Durity, a neurosurgeon and
humanitarian, has dedicated his
life to seeking out the best possible
neurosurgical care for British
Columbians. He founded the first
Canadian intracranial (brain) pressure monitoring unit at Vancouver
General Hospital and has served
on numerous hospital, university,
community national and international committees for neuroscience.
He also founded a Centre of
Excellence Project in Clinical
Neuroscience in Ghana, West Africa.
UBC Head Awarded Meritorious
Service Medal
The Canadian Government has
awarded Garth Warnock and his
research team a Meritorious Service
Medal in recognition of their breakthrough work in diabetes treatment.
Warnock, head of the Dept. of
Surgery at VGH and UBC,
developed a new diabetes treatment,
internationally known as the
Edmonton Protocol, with six other
The technique, which consists
of injecting healthy pancreatic islet
cells into diabetics to restore control
of blood glucose without further
need for daily insulin injections, is
now being taught by health facilities
around the world.
The group was presented with
one of 45 Medals, which
distinguishes achievements that
bring honour to the country.
Professor Elected to Academy of
James W Kronstad, a professor in
microbiology, has been elected to
Fellowship in the American
Academy of Microbiology.
The academy, an honorific group
within the American Society for
Microbiology, the world's oldest life
science organization, recognizes
scientific excellence and elects fellows annually based on their scientific achievement and original contributions that have advanced the field.
Kronstad has been recognized for
this leadership in the field of
moleculare mycology and expertise
in basidiomycete pathogens of plants
and humans. □
Peter Wall Institute
for Advanced Studies
Major Thematic Project Grant
The PWIAS Major Thematic Grant Program will be
accepting applications for the Fall 2005 competition.  It
is expected that only one award will be made this year.
The deadline is October 1.
The program provides major funding over three years
or more to a broad interdisciplinary team of UBC and
external scholars to research a new area of basic
research.  Prospective applicants should contact the
Institute Director, Dianne Newell, at the early stage in
Visit our web site at www.pwias.ubc.ca, or contact the
Wall Institute at (604) 822-4782. For specific program
details, visit www.pwias.ubc.ca/programs/mtg.php
UBC Public Affairs has opened both a radio and TV studio
on campus where you can conduct live interviews with local,
national and international media outlets.To learn more about
being a UBC expert, call us at 604.822.2064 and visit our
web site at www.publicaffairs.ubc.ca/experts/signup
M<l -. I„ . ■
Stratford Hall
Vancouver's only IB independent school
Offering the International Baccalaureate
Primary Years and Diploma Programmes.
Centrally located. Access via sky train.
For information, call 604.436.0608 orvisit www.stratfordhall.bc.ca
, Media
\T t1011 T> College of Health
V,1UUP Disciplines
Digital Printing &
Computer Imaging
Graphic Design & Illustration
Video & Media Production
AV Equipment & Media Sales
AV Services & Maintenance
Large Format Colour
3 feet (90cm) wide by as long as you require
Ideal for conference poster presentations.
Introducing the new high-resolution Epson
0 up to 44" wide
° up to 2880 dpi on photo-quality paper
heavyweight, photo-quality, and archival
papers available
= pricing from $9 to $11 per square foot      J
The Media Group
Woodward IRC Building, Rm B32
2194 Health Sciences Mall
Vancouver, BC V6T1Z3
Phone: (604) 822-5561 Fax: (604) 822-2004
Email: mediagrpts interchange.ubc.ca
www.mediagroup.ubc.ca IC      REPORTS      |      JULY     /,      2005
Did you know that the
University Town permanent
population is now close to
3000 people? When the Logan
Lane co-development project is
completed in August another
120 faculty and staff people
will join the University Town
lAfelCOITie to the new
University Town Times (the
publication formally known as
the University Town Report).
Along with this new look and
name we have a new editorial
mission: to put the issues related
to the development of University
Town in a form that folks who
do not hold a degree in urban
planning might understand
and actually find interesting.
A bold mission, we know! In
addition to planning updates we
thought you might like to know
more about the history of UBC,
community events, favorite
spots on campus, student and resident feedback, tips on getting around
and the like.
UBC is undergoing a major transformation. Eight new neighbourhoods
are proposed and several are already under construction. Our residential
population is increasing and, in many respects, and brand-new set of
community values is emerging. We hope this new publication helps
communicate these values and
gives an additional voice to the
University Town community.
Like the previous Reports we
will publish every second month.
What's new is that we will be
doing it within the V6T News,
the Ubyssey (Sept. - April) and
UBC Reports. Of course your
feedback is an essential ingredient
to everything we do, so please
give us your thoughts on this new
version by e-mailing us at
inf o.uni versity to wn@ubc. ca.
Have a wonderful
The University Neighbourhoods
Association (UNA) hosted a
BBQ with live music at the
UBC Botanical Gardens for
University Town residents on
May 26.
-ir* aw Twi
Barn Raising
Nothing brings a community together like a good
old-fashioned barn raising. Scheduled for completion
in early 2006 on the site of The Old Horse Barn - a
well-known UBC landmark - the Old Barn Community
Centre will be the dynamic new heart of the Hawthorn
Place neighbourhood. A contemporary architectural
interpretation of the original 1920's Pennsylvania Dutch
style dairy barn, the community centre will be 10,000
square feet of expansive, light-filled space and will
include a gym and exercise room, several multi-purpose
rooms, a 2,000 sq. ft. cafe, and an outdoor performance
stage. Plans also include a spacious daycare facility and
outdoor play area for 3-5 year old children.
fhe Stories
the Names
UBC is proud of it's rich history and the personalities
that have shaped it. Many of the neighbourhoods and
streets in University Town bear their names. Here are
just a few that reside in Hawthorn Place.
Drs. Harry and Audrey Hawthorn, founders of the
UBC Museum of Anthropology. Founded in 1947,
the Museum was directed in its early years by Harry
Hawthorn, the first anthropologist appointed to the
University faculty. Harry's wife Audrey Hawthorn
served as the first curator.
UBC Picks a Winner for University
Following six months of heated competition and 12 hours of debate by
an internationally renowned jury of architects UBC has chosen Team A
- Santa Monica's Moore Ruble Yudell Architects and Planners (MRY) and
Vancouver's Hughes Condon Marler: Architects (HCMA) - as the team
that will redesign University Boulevard and create a signature gateway and
new social heart for UBC. The campus community also voted Team A as
the favourite design by an overwhelming 79 per cent.
"We are absolutely thrilled by this outcome," said Dennis Pavlich, Chair
of the jury and UBC Vice-President, External and Legal Affairs. "The
jury's decision reflects a thoughtful and professional review of all the three
submissions - each unique and daring. Team A stood out for its exceptional
richness and vibrancy. The university community thought so too."
The competition jury concluded that Team A best addressed the functional program requirements and the spirit of University Boulevard. For more
information please visit www.universitytown.ubc.ca/archcomp
Public Hearing:
South Campus Land Use Changes
The GVRD has approved a date for the public hearing for the by-law to
amend land use designations in the UBC Official Community Plan (OCP).
The public hearing will take place on Wednesday, June 27, 2005 from 7pm
to 9pm in room 216 in UBC's Student Union Building.
The proposed by-law would change the location of the school, community centre and commercial centre to be consistent with locations proposed
in the South Campus Neighbourhood Plan. The amending bylaw would
also delete the research land use designation in the South Campus neighbourhood. All persons whose interests are affected by the by-law can make
oral or written submissions at the public hearing. To register as a delegation
or submit a written presentation to the GVRD Communities Committee
please contact the GVRD Corporate Secretary at 604-432-6250.
Dr. Larkin was an eminent fisheries biologist, well-
known and respected for his expertise in the areas of
conservation, resource management, and environmental
impact assessment. He joined the faculty of UBC in 1955
as professor of zoology and Director of the Institute of
Fisheries and retired in 1990 as professor in both the
Institute of Fisheries and the Department of Zoology.
Dr. Logan began teaching at the University of British
Columbia in 1920 where he was successively Instructor,
Assistant Professor, Associate Professor, Professor of
Classics and Head of the Department of Classics until
1952. Dr. Logan served in many capacities at UBC, but is
most remembered for his history of the university, Tuum
Est (1958).
University Town  UBC External Affairs Office  6328 Memorial Road, Vancouver BC V6T 1Z2  T: 604.822.6400   F: 604.822.8102  www.universitytown.ubc.ca


Citation Scheme:


Citations by CSL (citeproc-js)

Usage Statistics



Customize your widget with the following options, then copy and paste the code below into the HTML of your page to embed this item in your website.
                            <div id="ubcOpenCollectionsWidgetDisplay">
                            <script id="ubcOpenCollectionsWidget"
                            async >
IIIF logo Our image viewer uses the IIIF 2.0 standard. To load this item in other compatible viewers, use this url:


Related Items